Focus & Rulz Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Islamabad · Pakistan
Islamabad-based pharmaceutical manufacturer established in 2004 with domestic, export and toll-manufacturing operations.
Focus & Rulz Pharmaceuticals products in Pakistan
Focus & Rulz Pharmaceuticals (Pvt) Ltd has 102 medicine presentations registered in Pakistan under 45 brands, covering 37 generic medicines. Most of its products are in Anti-infectives, Vitamins, minerals & nutrition and CNS & mental health. Its brands with the most registered strengths and packs are Lectom (Levetiracetam), Ruzone (Ceftriaxone), Ciprulz (Ciprofloxacin) and M-Fer (Iron polymaltose complex, Elemental Iron). 102 products have an official DRAP price on MedInfoBase. See all 45 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Focus & Rulz Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 44 Industrial Triangle, Kahuta Road, Islamabad 44000, Pakistan · 44000
- Website
- focusandrulz.com ↗
- Phone
- +92 51 4493174
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Focus & Rulz Pharmaceuticals (Pvt) Ltd is priced against the market
93 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Angiocard | Nitroglycerin | 2.5 mg | Sustained-release capsule | 3x10's | 025098 | PKR 238.79 | PKR 7.96/capsule | No comparator |
| Angiocard | Nitroglycerin | 6.5 mg | Sustained-release capsule | 3x10's | 025099 | PKR 284.14 | PKR 9.47/capsule | No comparator |
| Arther | Artemether + Lumefantrine | 20 mg + 120 mg | Tablet | 16’s | 049292 | PKR 611.83 | PKR 38.24/tablet | 🔒 Pharma Pro |
| Arther | Artemether + Lumefantrine | 40 mg + 240 mg | Tablet | 8’s | 049306 | PKR 504.75 | PKR 63.09/tablet | 🔒 Pharma Pro |
| Arther Dry | Artemether + Lumefantrine | 15 mg + 90 mg/5 mL | Dry suspension | 60ml | 068894 | PKR 352.80 | PKR 5.88/mL | 🔒 Pharma Pro |
| Arther Dry | Artemether + Lumefantrine | 15 mg + 90 mg/5 mL | Dry suspension | 30 ml | 068894 | PKR 176.40 | PKR 5.88/mL | 🔒 Pharma Pro |
| Arther DS Dry | Artemether + Lumefantrine | 30 mg + 180 mg/5 mL | Dry suspension | 60ml | 072849 | PKR 588.01 | PKR 9.80/mL | 🔒 Pharma Pro |
| Arther DS Dry | Artemether + Lumefantrine | 30 mg + 180 mg/5 mL | Dry suspension | 30 ml | 072849 | PKR 274.40 | PKR 9.15/mL | 🔒 Pharma Pro |
| Arther Forte | Artemether + Lumefantrine | 80 mg + 480 mg | Tablet | 1x6’s | 066639 | PKR 630.94 | PKR 105.16/tablet | 🔒 Pharma Pro |
| Arther Forte | Artemether + Lumefantrine | 80 mg + 480 mg | Tablet | 1x4’s | 066639 | PKR 420.63 | PKR 105.16/tablet | 🔒 Pharma Pro |
| B.Pill 10 | Amlodipine + Valsartan | 10 mg + 160 mg | Tablet | 14's | 093367 | PKR 790.10 | PKR 56.44/tablet | 🔒 Pharma Pro |
| B.Pill 5 | Amlodipine + Valsartan | 5 mg + 80 mg | Tablet | 14's | 093368 | PKR 470.95 | PKR 33.64/tablet | 🔒 Pharma Pro |
| B.Pill 5 | Amlodipine + Valsartan | 5 mg + 160 mg | Tablet | 14's | 093369 | PKR 673.34 | PKR 48.10/tablet | 🔒 Pharma Pro |
| Beautic CreamRegistry verified | Fluocinolone Acetonide, Hydroquinone, Tretinoin | — | — | — | 069808Official source ↗ | No indexed price | — | — |
| Berrin 200mg CapsuleRegistry verified | Mebeverine HCl modified release (pellets) eq. to Mebeverine HCl | — | — | — | 066660Official source ↗ | No indexed price | — | — |
| Bumo | Silver sulfadiazine | 10 mg/g | Cream | 50g | 050917 | PKR 191.20 | PKR 3.82/g | 🔒 Pharma Pro |
| Bumo | Silver sulfadiazine | 10 mg/g | Cream | 250 g | 050917 | PKR 741.83 | PKR 2.97/g | 🔒 Pharma Pro |
| Ciprulz | Ciprofloxacin | 250 mg | Tablet | 1x10’s | 049297 | PKR 248.55 | PKR 24.86/tablet | 🔒 Pharma Pro |
| Ciprulz | Ciprofloxacin | 500 mg | Tablet | 1x10’s | 049298 | PKR 411.06 | PKR 41.11/tablet | 🔒 Pharma Pro |
| Ciprulz | Ciprofloxacin | 500 mg | Tablet | 10x10's | 049298 | PKR 3,840.90 | PKR 38.41/tablet | 🔒 Pharma Pro |
| Ciprulz | Ciprofloxacin | 125 mg/5 mL | Dry suspension | 60ml | 068892 | PKR 222.36 | PKR 3.71/mL | 🔒 Pharma Pro |
| Ciprulz | Ciprofloxacin | 250 mg/5 mL | Dry suspension | 60ml | 068893 | PKR 305.92 | PKR 5.10/mL | 🔒 Pharma Pro |
| Ciprulz 100ml | Ciprofloxacin | 200 mg | IV infusion | 100ml | 087367 | PKR 184.66 | PKR 1.85/mL | 🔒 Pharma Pro |
| Clarolid | Clarithromycin | 125 mg/5 mL | Dry suspension | 60ml | 068895 | PKR 426.36 | PKR 7.11/mL | 🔒 Pharma Pro |
| Clarolid | Clarithromycin | 250 mg | Tablet | 10's | 083503 | PKR 443.19 | PKR 44.32/tablet | 🔒 Pharma Pro |
| Clarolid | Clarithromycin | 500 mg | Tablet | 10's | 083504 | PKR 738.63 | PKR 73.86/tablet | 🔒 Pharma Pro |
| Clinda-V Vaginal | Clindamycin | 20 mg/g | Cream | 40g | 049302 | PKR 609.47 | PKR 15.24/g | 🔒 Pharma Pro |
| Cloteen-V | Clotrimazole | 20 mg/g | Cream | 35g (with applicator) | 049303 | PKR 180.67 | — | No comparator |
| Cloteen-V | Clotrimazole | 500 mg | Vaginal tablet | 1’s | 066640 | PKR 135.90 | PKR 135.90/tablet | 🔒 Pharma Pro |
| Cycloz | Aciclovir | 50 mg | Cream | 10g | 012390 | PKR 541.50 | PKR 54.15/g | No comparator |
| Cycloz | Aciclovir | 400 mg | Tablet | 25’s | 026188 | PKR 1,030.14 | PKR 41.21/tablet | 🔒 Pharma Pro |
| Cycloz | Aciclovir | 800 mg | Tablet | 25’s | 026688 | PKR 1,911.94 | PKR 76.48/tablet | 🔒 Pharma Pro |
| Dexorulz 30mg CapsuleRegistry verified | Dexlansoprazole dual delayed release pellets 22.5% eq. to Dexlansoprazole | — | — | — | 124977Official source ↗ | No indexed price | — | — |
| Dexorulz 60mg CapsuleRegistry verified | Dexlansoprazole dual delayed release pellets 22.5% eq. to Dexlansoprazole | — | — | — | 124978Official source ↗ | No indexed price | — | — |
| Etamol | Paracetamol | 120 mg/5 mL | Oral suspension | 120ml | 102365 | PKR 95.38 | PKR 0.79/mL | 🔒 Pharma Pro |
| Etamol | Paracetamol | 120 mg/5 mL | Oral suspension | 60ml | 102365 | PKR 66.01 | PKR 1.10/mL | 🔒 Pharma Pro |
| Etel | Escitalopram | 5 mg | Tablet | 14's | 049310 | PKR 376.31 | PKR 26.88/tablet | 🔒 Pharma Pro |
| Etel | Escitalopram | 10 mg | Tablet | 14’s | 049311 | PKR 847.64 | PKR 60.55/tablet | 🔒 Pharma Pro |
| F-CQ | Chloroquine | 200 mg | Tablet | 50's | 101880 | PKR 722.57 | PKR 14.45/tablet | No comparator |
| F-CQ | Chloroquine | 200 mg | Tablet | 30’s | 101880 | PKR 433.54 | PKR 14.45/tablet | No comparator |
| Fexfad | Fexofenadine | 60 mg | Tablet | 10's | 049295 | PKR 133.19 | PKR 13.32/tablet | 🔒 Pharma Pro |
| Fexfad | Fexofenadine | 120 mg | Tablet | 10’s | 049296 | PKR 280.92 | PKR 28.09/tablet | 🔒 Pharma Pro |
| Flurulz | Fluconazole | 150 mg | Capsule | 1's | 049299 | PKR 263.84 | PKR 263.84/capsule | 🔒 Pharma Pro |
| Fociquin | Chloroquine | 250 mg | Tablet | 500's | 101881 | PKR 619.81 | PKR 1.24/tablet | 🔒 Pharma Pro |
| Fociquin | Chloroquine | 50 mg/5 mL | Syrup | 60ml | 101882 | PKR 19.27 | PKR 0.32/mL | 🔒 Pharma Pro |
| Helezol | Omeprazole | 20 mg | Capsule | 2x7's | 027104 | PKR 280.37 | PKR 20.03/capsule | 🔒 Pharma Pro |
| Helezol | Omeprazole | 40 mg | Capsule | 2x7's | 051054 | PKR 477.98 | PKR 34.14/capsule | 🔒 Pharma Pro |
| Lectom | Levetiracetam | 500 mg | Tablet | 30's | 063484 | PKR 2,884.84 | PKR 96.16/tablet | 🔒 Pharma Pro |
| Lectom | Levetiracetam | 500 mg | Tablet | 10’s | 063484 | PKR 961.62 | PKR 96.16/tablet | 🔒 Pharma Pro |
| Lectom | Levetiracetam | 1000 mg | Tablet | 30's | 063485 | PKR 4,808.07 | PKR 160.27/tablet | 🔒 Pharma Pro |
All 45 Focus & Rulz Pharmaceuticals brands in Pakistan
- Angiocard Nitroglycerin · 2.5 mg capsule, 6.5 mg capsule
- Arther Artemether + Lumefantrine · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet
- Arther Dry Artemether + Lumefantrine · 15 mg + 90 mg/5 mL suspension
- Arther DS Dry Artemether + Lumefantrine · 30 mg + 180 mg/5 mL suspension
- Arther Forte Artemether + Lumefantrine · 80 mg + 480 mg tablet
- B.Pill 10 Amlodipine + Valsartan · 10 mg + 160 mg tablet
- B.Pill 5 Amlodipine + Valsartan · 5 mg + 160 mg tablet, 5 mg + 80 mg tablet
- Bumo Silver sulfadiazine · 10 mg/g cream
- Ciprulz Ciprofloxacin · 125 mg/5 mL suspension, 250 mg tablet, 250 mg/5 mL suspension
- Ciprulz 100ml Ciprofloxacin · 200 mg infusion
- Clarolid Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Clinda-V Vaginal Clindamycin · 20 mg/g cream
- Cloteen-V Clotrimazole · 20 mg/g cream, 500 mg pessary
- Cycloz Aciclovir · 400 mg tablet, 50 mg cream, 800 mg tablet
- Etamol Paracetamol · 120 mg/5 mL suspension
- Etel Escitalopram · 10 mg tablet, 5 mg tablet
- F-CQ Chloroquine · 200 mg tablet
- Fexfad Fexofenadine · 120 mg tablet, 60 mg tablet
- Flurulz Fluconazole · 150 mg capsule
- Fociquin Chloroquine · 250 mg tablet, 50 mg/5 mL syrup
- Helezol Omeprazole · 20 mg capsule, 40 mg capsule
- Lectom Levetiracetam · 100 mg/mL solution, 1000 mg tablet, 500 mg tablet
- Lectom Oral Levetiracetam · 100 mg/mL solution
- M-Fer Iron polymaltose complex, Elemental Iron · 100 mg tablet, 50 mg/5 mL syrup
- Malt Iron polymaltose complex + Folic acid, Iron + Folic acid · 100 mg + 0.35 mg tablet, 50 mg elemental iron + 0.35 mg folic acid/5 mL syrup, 50 mg/5 mL + 0.35 mg/5 mL syrup
- Merovite Meropenem · 1 g injection
- Merovite Injectiom Meropenem · 500 mg injection
- Mico Scalp Miconazole · 20 mg/g gel
- Moxirulz Moxifloxacin · 400 mg tablet
- Muriban Mupirocin · 20 mg ointment
- Neopres Amlodipine · 10 mg tablet, 5 mg tablet
- Omper Omeprazole · 20 mg capsule
- Prolen Ibuprofen · 100 mg/5 mL suspension
- Rulozine Zinc · 20 mg/5 mL syrup
- Ruzone Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Senergy OD Loratadine · 1 mg/mL suspension, 10 mg tablet
- Sp-mal Artesunate · 100 mg tablet
- Sudolyt ORS Lemon Flavour Sodium chloride + Potassium chloride + Trisodium citrate dihydrate + Glucose anhydrous · 2.6 g + 1.5 g + 2.9 g + 13.5 g sachet
- Sudolyt ORS Orange Flavour Sodium chloride + Potassium chloride + Trisodium citrate dihydrate + Glucose anhydrous · 2.6 g + 1.5 g + 2.9 g + 13.5 g sachet
- Tenv Tenofovir disoproxil · 300 mg tablet
- Trag Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Vfix Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 200 mg/5 mL suspension
- Woff Levofloxacin · 250 mg tablet, 500 mg tablet
- Zolincid Linezolid · 100 mg/5 mL suspension, 600 mg tablet
- Zotter Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 500 mg capsule
Focus & Rulz Pharmaceuticals: common questions
How many products does Focus & Rulz Pharmaceuticals have in Pakistan?
Focus & Rulz Pharmaceuticals (Pvt) Ltd has 102 registered medicine presentations in Pakistan, sold under 45 brands and covering 37 generic medicines.
What are the main brands of Focus & Rulz Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Lectom (Levetiracetam), Ruzone (Ceftriaxone), Ciprulz (Ciprofloxacin), M-Fer (Iron polymaltose complex, Elemental Iron) and Malt (Iron polymaltose complex + Folic acid, Iron + Folic acid). This is not a sales ranking.
Which therapy areas does Focus & Rulz Pharmaceuticals cover?
The most products are in Anti-infectives (59), Vitamins, minerals & nutrition (11), CNS & mental health (10), Cardiovascular (7) and Pain & musculoskeletal (4).
Where can I see Focus & Rulz Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.